Although CD74 overexpression is mostly associated with hematologic malignancies, it has also been reported in non‐hematopoetic cancers such as gastric, renal, urinary bladder, non‐small cell lung cancer certain sarcomas and glioblastomas [53, 54, 55, 56, 57]. Here, CD74 is linked to cancer.